Blue Bell Private Wealth Management, LLC Veracyte, Inc. Transaction History
Blue Bell Private Wealth Management, LLC
- $499 Million
- Q3 2024
A detailed history of Blue Bell Private Wealth Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Blue Bell Private Wealth Management, LLC holds 85 shares of VCYT stock, worth $3,689. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85
Previous 85
-0.0%
Holding current value
$3,689
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
307Shares Held
81.7MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$338 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$336 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$218 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$214 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$184 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.11B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...